New eye drops target misery of seasonal allergies
NCT ID NCT06602739
Summary
This study tested whether two experimental drugs, given together as eye drops, could safely reduce the signs and symptoms of eye allergies caused by birch pollen. In this Phase 3 trial, 54 adults with a confirmed birch pollen allergy received either the real treatment or a placebo (a look-alike with no medicine) to compare their effects. Researchers measured how well the treatment reduced eye itch, redness, and tearing after a controlled pollen challenge.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
-
Clinique de Specialisee en Allergie de la Capitale
Québec, G1V 4W2, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
Conditions
Explore the condition pages connected to this study.